Deslodin

Quick links to important sections

Deslodin

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Deslodin

What is Deslodin?

Deslodin is a medicinal product used to manage symptoms associated with allergic reactions. It belongs to a category of medications known as antihistamines, specifically classified as a non-sedating, long-acting tricyclic antagonist with selective peripheral H1-receptor histamine activity.

Active Ingredient

The primary active substance in Deslodin is desloratadine. Desloratadine is the major active metabolite of loratadine. It works by blocking the action of histamine, a natural substance in the body that initiates inflammatory and allergic responses when the immune system reacts to foreign allergens.

Mechanism of Action

Unlike older antihistamines, Deslodin is designed to target peripheral histamine receptors rather than those in the central nervous system. This selectivity is intended to minimize the occurrence of drowsiness while effectively inhibiting the cascade of allergic symptoms, such as sneezing, itching, and watery eyes.

Primary Uses

Deslodin is typically used for the relief of symptoms related to two main conditions:

  • Allergic Rhinitis: This includes seasonal allergies (hay fever) and perennial allergies (caused by dust mites, mold, or pet dander). It helps alleviate nasal congestion, rhinorrhea (runny nose), and nasal itching.
  • Urticaria: It is used to manage symptoms of hives, specifically to reduce itching and the number and size of wheals on the skin.

What side effects are possible with Deslodin?

Possible Side Effects and Safety Information

The safety profile of Deslodin (desloratadine) is defined by officially documented adverse reactions that are classified according to frequency and the body system affected, consistent with regulatory labeling standards. The medicine is formally contraindicated in individuals with known hypersensitivity to desloratadine, any of its excipients, or the precursor drug, loratadine.


Common and Rare Adverse Reactions

Side effects are typically categorized by frequency based on clinical trials and post-marketing surveillance. Adverse reactions classified as Common (affecting up to 1 in 10 patients) primarily involve the Nervous System and Gastrointestinal System, and include headache, fatigue, and dry mouth in adults and adolescents. These common effects may be more frequently observed at the start of treatment.

Less frequent, Very Rare adverse reactions (affecting less than 1 in 10,000 patients) involve multiple system-organ classes and include specific serious reactions.

System-Organ Class Very Rare Adverse Reactions (Examples)
Immune System Anaphylaxis, angioedema (severe swelling)
Hepatobiliary System Hepatitis, elevated liver enzymes, jaundice
Nervous System Seizures, hallucinations, psychomotor hyperactivity
Cardiovascular System Tachycardia (rapid heartbeat), palpitations

Population-Specific Safety Considerations

Official prescribing information includes caution for use in specific populations. Deslodin should be used with caution in patients with severe renal impairment and severe hepatic impairment due to the potential for increased systemic exposure to the drug. Specific pediatric data indicates that the overall safety profile is similar to adults, though specific common effects in infants (6 to 23 months) include diarrhea, fever, and insomnia.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes the presentation of an overdose with Deslodin (desloratadine) as generally involving adverse events similar to those seen at therapeutic doses, but with a potentially greater magnitude.

Documented Overdose Manifestations

Symptoms and adverse events specifically reported in the context of overdose or post-marketing surveillance include the following:

  • Cardiovascular: Arrhythmia (irregular heartbeat), bradycardia (slow heart rate), and QT prolongation (a change in the heart's electrical activity).
  • Neurological/Behavioral: Abnormal behavior and aggression.

Clinical trials involving high doses, up to 45 mg (nine times the usual recommended daily dose), observed no clinically relevant changes to the safety profile, including the corrected QT interval. However, the potential for severe, documented complications necessitates immediate medical attention if an overdose is suspected.

Emergency Response

When to Seek Immediate Medical Help:

If more Deslodin is taken than prescribed, patients are directed to inform a doctor, pharmacist, or nurse immediately. Due to the risk of serious complications, urgent medical assessment is necessary.

Official Management Protocol:

  • Standard measures to remove any unabsorbed medication from the body should be considered.
  • Treatment is primarily symptomatic and supportive, meaning it focuses on addressing the symptoms that arise and maintaining vital functions.
  • Desloratadine cannot be effectively removed from the body by hemodialysis.

Therapeutic Uses of Deslodin

Main Uses and Benefits

Deslodin is a non-sedating antihistamine used to manage symptoms associated with allergic conditions. It works by blocking the action of histamine, a substance in the body that causes allergic reactions.

Allergic Rhinitis

The medication is primarily used to relieve symptoms of allergic rhinitis, which include:

  • Sneezing
  • Runny or itchy nose
  • Congestion or stuffiness
  • Itchy, red, or watery eyes
  • Itching of the palate

It is effective for both seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis, which occurs year-round due to indoor allergens like dust mites or pet dander.

Urticaria (Hives)

Deslodin is also indicated for the treatment of urticaria. It helps to alleviate the symptoms of chronic idiopathic urticaria, such as:

  • Itching (pruritus)
  • The appearance of hives or welts on the skin

Benefits

As a long-acting antihistamine, the medication provides relief that typically lasts for 24 hours. Because it belongs to the newer generation of antihistamines, it does not readily enter the brain from the blood, which means it is significantly less likely to cause drowsiness compared to older allergy medications. This profile allows individuals to manage their allergy symptoms while maintaining their usual daily activities.

Eligibility and Restrictions for Use

Deslodin (desloratadine) eligibility is defined by official regulatory documentation, outlining who is permitted to use the medicine and who must be excluded or use it with caution.

Eligibility Scope

Scope Regulatory Status
Populations for whom use is allowed Adults and adolescents aged 12 years and older are generally eligible. Children 6 months of age and older are eligible for certain oral formulations, subject to regional approval.
Populations for whom use is contraindicated Patients with known hypersensitivity to the active substance, to the excipients, or to the precursor drug loratadine.
Age-related eligibility rules Use is not recommended in infants below 6 months of age as safety and efficacy have not been established. Tablet formulations are typically authorized only for children 6 years and older or 12 years and older, depending on the tablet strength and region.
Condition-specific eligibility rules Patients with severe renal impairment or severe hepatic impairment must use the medicine with caution due to increased drug exposure. Caution is also advised for patients with a medical or familial history of seizures.
Reproductive status Use is not recommended during pregnancy as a precautionary measure, and it is not recommended for women who are breastfeeding, as desloratadine is excreted in breast milk.

Official documents define eligibility around these constraints, providing clear rules on who is eligible for standard use and who requires conditional or restricted use.

What should I know about interactions with other medicines?

Deslodin Interactions with other medicines and products

Interaction Scope

Official regulatory documents confirm specific pharmacokinetic interactions but no formally contraindicated drug-drug combinations. Substances documented as increasing Deslodin’s systemic exposure (AUC and C max) include Erythromycin, Ketoconazole, Cimetidine, Fluoxetine, and Azithromycin. Although these agents alter the plasma concentrations of Deslodin and its metabolite, the enzyme responsible for Desloratadine's metabolism remains generally unidentified in primary regulatory sources. In vitro data suggests the drug is not a significant P-glycoprotein inhibitor.

Interaction-Context Constraints

The product's interaction profile is characterized by a formal absence of certain effects. Clinical trials found that Deslodin does not potentiate the performance-impairing effects of alcohol or increase somnolence when co-administered. Furthermore, the drug’s disposition is officially documented as being unaffected by either a high-fat meal or the consumption of grapefruit juice. No specific mandatory timing rules for dose separation are documented in the labeling.

Population-Specific Cautions

Regulatory information notes that patients with severe hepatic impairment or severe renal impairment exhibit slower clearance, resulting in increased systemic drug exposure (AUC and C max). The overall regulatory classification for the observed pharmacokinetic interactions asserts that the increased exposure resulting from co-administration of the listed inhibitors does not result in a clinically relevant change in the safety profile.

Mechanism of Action

The mechanism of Deslodin is defined by its selective and high-affinity action within the histamine signaling system, resulting in defined physiological consequences without affecting central brain function. The core mechanism involves selective antagonism at the peripheral Histamine H1-receptors. By stabilizing these receptors in an inactive state (inverse agonism), the drug directly blocks the ability of endogenous histamine to bind and trigger its signaling cascade, which is the key molecular step that precedes all subsequent physiological effects.

This receptor blockade initiates a cascade that modulates several physiological consequences, including the vascular permeability pathway and the sensory nerve activation pathway. By limiting the signaling that leads to capillary leakage and nerve stimulation, the mechanism dampens localized fluid extravasation and pruritus signaling, adjusting the activity of the histamine-mediated physiological response in peripheral tissues. A critical domain of action is the molecule's inability to significantly cross the Blood-Brain Barrier (BBB), maintaining functional CNS exclusion. This structural constraint restricts the drug's activity to the body's periphery, preventing the interference with central regulatory functions like wakefulness.

Dosage and Administration Information

Official Administration Guidelines

Deslodin (desloratadine) is administered via the oral route, including film-coated tablets, orally disintegrating tablets, and oral solution forms. The standardized approach to using the medicine is based on a once-daily schedule, which is maintained across all approved age groups and indications.


Labeled Dosing Regimens

Patient Group Daily Dose (For Approved Indications)
Adults and Adolescents (12 years and older) 5 mg once daily
Children (6 to 11 years) 2.5 mg once daily
Infants (6 to 11 months) 1 mg once daily (via Oral Solution)

Administration Context and Adjustments

  • Timing: The dose may be taken with or without food.
  • Specific Forms: The oral solution must be measured precisely using a calibrated measuring device. Orally disintegrating tablets should be placed on the tongue to disintegrate rapidly and swallowed with saliva.
  • Dosing Frequency Adjustment: For adult patients with renal or hepatic impairment, the starting frequency is typically reduced to 5 mg every other day.

Missed Dose and Duration

If a dose is missed, it should be taken as soon as possible, unless it is almost time for the next scheduled dose; a double dose must not be taken. The duration of use for allergic rhinitis is based on the presentation: intermittent rhinitis may allow treatment to be discontinued upon symptom resolution and reinitiated when symptoms reappear, while persistent rhinitis may involve continuous treatment during allergen exposure periods.

Recent Clinical Evidence

Deslodin: Recent Clinical Evidence

Evidence for Use in Allergic Rhinitis

The research base for this context includes short-term, double-blind, placebo-controlled Randomized Controlled Trials (RCTs) and Meta-analyses conducted in Adults and Adolescents. Studies explored conditions characterized by fluctuating manifestations like allergic rhinitis. Research examined outcomes related to physical discomfort, such as the Total Symptom Score (TSS), a standardized method used in research exploring how symptoms change over time. Findings describe patterns observed where the group receiving the medicine reported changes in TSS and changes in patient-reported Quality of Life scores compared to the placebo group.

Evidence for Use in Chronic Idiopathic Urticaria (Hives)

This medicine was studied for use in conditions involving periods of heightened symptoms, such as chronic idiopathic urticaria (hives). The evidence relies on multiple RCTs and observational studies. The main outcomes monitored were the Urticaria Activity Score (UAS), which assesses outcomes related to physical discomfort (itching and hives). Research explored short-term symptom changes, tracking outcomes reflecting daily functioning or activity level. Studies reported how symptoms evolved in the observed populations, noting patterns related to both itching score and the number of hives in the medicine group compared to the placebo. Findings contribute to understanding changes observed in interference with sleep and daily activities over the study period.

Long-Term Outcomes and Special Populations

The follow-up durations were limited in the primary research studies, often lasting two to six weeks. Because of this, long-term effects are not fully established, meaning the evidence does not extensively characterize the long-term outcomes or the durability of symptom patterns. Studies in children aged 6 months and older monitored results that were comparable to those observed in adults. However, data for certain groups—such as pregnant populations or those with severe organ problems—remain insufficient. Certainty remains low regarding the overall evidence landscape, and comparative evidence is lacking against every similar medicine currently available.

Key Studies & References

  1. Efficacy of desloratadine in the treatment of allergic rhinitis: a meta-analysis of randomized, double-blind, controlled trials
  2. BSACI guideline for the management of chronic urticaria and angioedema (Provides context for treatment approach and updosing limitations)

Frequently Asked Questions (FAQ)

Common questions about Deslodin (FAQ)


Q: Is Deslodin the same type of medication as Allegra or Claritin?

Deslodin (desloratadine) is a second-generation antihistamine. It belongs to the same pharmacological class, known as H1-receptor antagonists, as medications like Allegra (fexofenadine) and Claritin (loratadine).


Q: How quickly does Deslodin usually start to work for allergy symptoms?

Official studies indicate that antihistaminic effects are typically observed within one hour after taking a dose. Regulatory sources note that symptom improvement may be observed as early as one day after starting the therapy.


Q: Can Deslodin cause drowsiness, even though it's supposed to be non-sedating?

Deslodin is classified as a non-sedating antihistamine because it has very limited ability to affect the central nervous system. However, somnolence, which is unusual drowsiness or sleepiness, has been reported as an adverse reaction in clinical trials, although usually at a rate similar to or only slightly higher than placebo.


Q: How long does the effect of Deslodin last after taking one dose?

Official pharmacological data show that the antihistaminic effects of Deslodin are generally sustained for up to 24 hours following a single dose.


Q: Are there any common foods or drinks that should be avoided while on Deslodin?

According to regulatory documents, the effects of Deslodin are not altered by the consumption of a high-fat meal or by drinking grapefruit juice. No other specific food or drink restrictions are generally documented in the official product labeling.


Q: Is Deslodin generally considered safe to use during pregnancy for allergy relief?

Official guidance is that use is not recommended during pregnancy as a precautionary measure. This is because clinical data on the use of desloratadine in pregnant women are currently limited or considered insufficient.


Q: Can Deslodin be used for hives (urticaria) that aren't caused by an allergy?

Deslodin is indicated for the relief of symptoms associated with chronic idiopathic urticaria (hives of an unknown cause). This means its authorized use is not restricted only to hives with a known allergic trigger.


Q: What should you do if you experience unusual side effects while on Deslodin?

Official labeling advises that if severe hypersensitivity reactions occur—such as severe swelling (angioedema), difficulty breathing, or rash—treatment should be stopped immediately. If these occur, the reactions warrant immediate medical assessment and consideration for alternative treatment.


Q: Are there any heart-related concerns linked to taking Deslodin?

Very rare adverse effects, such as a rapid heartbeat (tachycardia) and palpitations, have been reported. However, clinical trials using high doses of the medication found no clinically relevant changes to the heart's electrical activity, specifically the QTc interval.


Q: Is it normal to feel slightly jittery or nervous when first starting Deslodin?

Official documentation lists psychomotor hyperactivity, which could include feelings of restlessness or jitters, as a very rare side effect. These feelings are not documented among the commonly experienced adverse effects.


Q: Can Deslodin be taken at night or is it better to take it in the morning?

Deslodin is a once-daily medicine. The official regulatory labeling does not specify a required time of day, such as morning or night, for the medication to be taken.


Q: Are there generic versions of Deslodin available?

Yes, regulatory authorities have approved generic drug applications for the active ingredient, desloratadine. Therefore, generic versions are available in various authorized forms, including tablets and oral solutions.


Q: Can Deslodin be used to treat swelling or angioedema?

The medication is indicated for chronic idiopathic urticaria (hives), a condition that may involve localized swelling. However, official regulatory documents do not explicitly list the product as an acute treatment for severe swelling or angioedema itself.


Q: Is there a maximum length of time Deslodin can be taken continuously?

For patients suffering from persistent allergic rhinitis, continuous treatment may be proposed during periods of allergen exposure. For these patients, this is an approach that does not specify a fixed, absolute maximum duration in the labeling.


Q: If I have a history of glaucoma, can I still take Deslodin?

The core Deslodin product is not contraindicated for glaucoma. However, it is noted that combination products containing Deslodin along with a decongestant (like pseudoephedrine) are typically contraindicated for individuals with narrow-angle glaucoma.


Q: Do older adults (seniors) need to take a lower dose of Deslodin?

Based on pharmacokinetic studies, although the drug exposure may be slightly higher in older adults (65 years and above), the difference was not considered clinically relevant. Therefore, no dosage adjustment is officially recommended solely based on advanced age.


Q: Why is Deslodin preferred over diphenhydramine (Benadryl) in many cases?

Deslodin is a second-generation antihistamine which is classified as non-sedating. This structural classification means it has very limited ability to cross the Blood-Brain Barrier (BBB), unlike older, first-generation compounds such as diphenhydramine, which commonly cause sedation.


Q: Can taking Deslodin cause any changes in laboratory blood test results?

Very rare adverse reactions documented in the official information include the reporting of elevated liver enzymes and jaundice. These are changes that would typically be detected through standard laboratory blood tests used to check liver function.

How should Deslodin be stored and disposed of?

Storage and Disposal Requirements

The official labeling for Deslodin (desloratadine) defines specific conditions required to maintain the medicine's stability and ensures safe handling.

Requirement Official Condition
Maximum Temperature Do not store above 30^circC (86^circF).
Protection Store in the original package to protect from moisture and, for some forms, light.
Child Safety Keep out of the sight and reach of children.
Disposal Rule No special requirements for disposal of the unused product; discard in accordance with local requirements.

These requirements strictly mandate temperature control and protection from environmental factors to prevent degradation. Disposal of expired or unused medicine is generally not classified as hazardous waste for the end-user, but must comply with local guidelines for discarding pharmaceuticals.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Deslodin found in:

A-Z Index: